This study compares effective doses associated with 2D lateral, oblique, and AP radiographs with 3D MDCT and Cone Beam CT images of the foot and ankle.
visualization of separate bony structures [4, 5] ; however, this examination is expensive, limited in availability to hospitals and large radiology practices, and is associated with significantly increased x-ray dose in relation to plain views.
Cone Beam CT (CBCT) represents a less expensive alternative to MDCT that has found increasing application in radiation therapy planning / monitoring and maxillofacial imaging over the last decade. While limited in its ability to visualize soft tissue structures, this modality is perhaps ideally suited to providing definitive imaging of the osseous components of the foot and ankle.
It has been estimated that from 1.5% to 2% of all US cancers may be attributed to computed tomography (CT) studies alone [6] . Medical CT scan doses vary widely depending on the anatomic region and purpose of the scan [7] . Dose is especially important when considering the adolescent and pediatric populations in whom cellular growth and organ development is associated with increased radiosensitivity of tissues. In conjunction with a longer life expectancy in which cancer can develop, children may be two times to five times more sensitive to radiation carcinogenesis as mature adults [7, 8] . In its applications in head and neck imaging, CBCT has been suggested as a low dose alternative to MDCT [9] . While the majority of CBCT examinations have been reported to impart a much lower dose, CBCT units from different manufacturers have been shown to vary in patient dose 10-fold for an equivalent field of view (FOV), with some units roughly equivalent in dose to optimized CT scans [10] . Although experimental [11] , and commercial [12] , CBCT units have been developed for extremity imaging, the PedCAT® (CurveBeam, Warrington, PA) is the first application of CBCT dedicated to weightbearing imaging of the foot and ankle.
Because dose is a general concern in diagnostic imaging and cost and risks of imaging must be weighed against anticipated benefits of improved diagnosis and resulting management, it is important to define the risk of any radiographic examination. We are unaware of contemporary reports of dose and risk from CT imaging of the foot and ankle. Therefore, the aim of this research is to acquire and compare effective dose data for foot / ankle scanning using 3D CBCT and MDCT methods as well as 2D transmission radiography imaging.
Methods
An anthropomorphic phantom of the foot and ankle was constructed permitting localization of dosimeters within and on tissues /anatomy of interest (see Figure 1 ). The phantom was constructed using the lower leg, ankle, and foot bones of a human skeleton, which was embedded in a radiologically soft-tissue-equivalent material approximating the form of the lower adult extremity (The Phantom Laboratory, Salem, NY). The foot and ankle portion of the phantom was fabricated in 25 mm horizontally sliced layers allowing separation and specific localization of dosimeters within each layer. Slots were drilled in the surface of the layers to accommodate placement of dosimeters in tissues used in the 2007 ICRP calculation of effective dose (see Table 1 ). Additional dosimeters were placed in surface areas to measure skin dose. Twenty-one dosimeter locations were utilized (see Figure 2 ). The unit operates at 100 to 120 kVp and 3 to 5 mA producing a single foot scan in 19 seconds. Sixteen warm up frames and 361 data frames are acquired during the scanning sequence. A pulsed exposure of 12 msec for standard scans and 18 msec for grid filtered scans is utilized producing scan exposures of 4.5 to 6.8 mAs.
MDCT dosimetry was acquired using a Siemens Somatom Definition AS (Siemens Medical Solutions USA, Malvern, PA) using standard and automatic exposure control (CARE Dose) foot imaging protocols. The unit was operated at 120 kVp, 55 mAs and pitch of 0.55 (effective mAs set to 100) while acquiring a 20 cm length extending from the base of the foot. With CARE Dose on, the mAs was reduced, resulting in average effective mAs of 89 (average mAs of 48.95). Both scans were acquired using 38.4 mm longitudinal beam dimension (128 row * 0.6 mm row height detector configuration with flying focal spot).
Conventional 2D radiographic imaging dosimetry was produced with Siemens x-ray tube Optiptop 150/40/80HC. Exposures were made at suggested medium adult settings of 60 kVp with 3.6 mAs for AP and Oblique views and 4.5 mAs for the lateral view. Sample images from each modality are seen in Figure 3 . Optically stimulated luminescent dosimeters (OSL) (Nanodot, Landauer, Inc., Glenwood, IL) were used for dosimetry for this project. NanoDots are plastic disks infused with aluminum oxide doped with carbon (Al 2 O 3 : C). The trace amounts of Carbon in the Al 2 O 3 crystal lattice create imperfections that act as traps (F centers) for electrons or holes. After exposure to ionizing radiation, free electrons and holes are generated and trapped at the F centers in proportion to the amount of energy in the exposure. Energy captured by the F centers is reemitted as light when electrons or holes recombine. This occurs when the crystal is optically stimulated with a controlled exposure of 540 nm light from a light emitting diode. The energy released from F centers can be distinguished from the stimulating light because it is emitted in the form of 420 nm photons. The intensity of the emitted luminescence depends on the dose absorbed by the OSLD and the intensity of the stimulation light. This intensity is proportional to the stored dose and is recorded by a photomultiplier tube that incorporates a filter that screens out photons from the stimulating light source. Each dosimeter is encased in a light-tight plastic holder measuring approximately 1 mm ×10 mm× 10 mm. This case prevents loss of energy through stimulation by ambient light. Dosimeters used in this study were read with a portable reader (MicroStar, Landauer, Inc., Glenwood, IL). The reader was calibrated before use. Following calibration, photon counts from dosimeters were recorded with an accuracy of ~+/-2%. Photon counts were converted to dose using an energy specific conversion factor (ECF).
Multiple exposures were utilized for some dosimeter runs to provide a more reliable measure of radiation in the dosimeters. OSLD doses recorded by the reader were divided by the number of scans (or projections for plain film techniques) to determine the 'exposure per examination' for each dosimeter. Dosimeter values were adjusted for energy response of the OSL material using polynomial smoothing of data presented in a white paper by Landauer Inc. [13] The best-fit equation for determining an energy conversion factor was ECF =3×10 -6 × 0.67 kVp 3 -0.0007 × 0.67 kVp 2 + 0.0453 × 0.67 kVp + 0.1005.
Doses from OSLDs at different positions within a tissue or organ were averaged to express the average tissue-absorbed dose in micrograys (µGy). The products of these values and the percentage of a tissue or organ irradiated in a radiographic examination were used to calculate the equivalent dose (H T ) in micro-Sieverts (µSv) [14] . The tibia fraction that is irradiated in different field sizes is seen in Table 2 . For bone marrow, the equivalent dose to the whole-body bone marrow was calculated using the summation of the individual equivalent doses to the ankle and foot bones and tibia and fibula. The determination of these equivalent doses was based on the distribution of active bone marrow throughout the body and was calculated for different ages (see Table 3 ) [15] . Active marrow is not typically located in the bones of the foot after the age of 10 or the tibia and fibula after the age of 15 [16] . For bone surface, a correction factor based on experimentally determined mass energy attenuation coefficients for bone and muscle irradiated with mono-energetic photons was applied. An effective beam energy estimated to be 2/3rds of the peak beam energy for the x-ray unit was used to determine bone /soft tissue attenuation ratios. A linear fit (R 2 =0.996) of ratios from 40 to 80 kV from published data [17] produced the following equation: bone /muscle attenuation ratio = -0.0618 x 0.67 kVp + 6.9406. The proportion of skin surface area in the foot and ankle region directly exposed during CBCT imaging is estimated as 5% of the total body for a 30 cm scan volume, 4% for a 20 cm scan volume and 3% for a 10 cm scan volume to calculate radiation weighted dose to the skin. Similarly, bone surface and muscle exposures are estimated to represent 5%, 4%, or 3% of the total body complement for these tissues for the 30 cm, 20 cm, and 10 cm volumes respectively.
Effective dose (E) is a calculation that permits comparison of the detriment of different exposures to ionizing radiation to an equivalent detriment produced by a full body dose of radiation. E, expressed in µSv, is calculated using the equation: E = w T x H T , where E is the summation of the products of the tissue weighting factor (w T ), which represents the relative contribution of that organ or tissue to the overall risk, and the equivalent dose H T [14] . The whole-body risk is found by the summation of the equivalent doses to all tissues or organs exposed [14] .
Tissue weighting factors used in the 2007 ICRP calculation of effective dose include 14 independently weighted tissues and a group of 14 remainder tissues. Because the uterus/cervix is present only in females, and prostate only in males, the number used in the weighted averaging of remainder tissues is 13. Of remainder tissues, only muscle is directly exposed in foot and ankle imaging. Therefore, remainder dose was calculated from muscle located dosimeters and multiplied by the % full body distribution (3% to 5%), the proportional contribution to remainder weight (0.08), and the remainder weight (0.12).
ISSN 2331-5857 E-ISSN 2331-5865 6 The risk of cancer developing years after exposure to ionizing radiation is the principle health related concern associated with diagnostic radiographic imaging. The ICRP has determined that a cancer risk coefficient of 5.5 × 10 -2 Sv -1 is consistent with currently available data [14] . Table 4 demonstrates effective dose calculations for large FOV CBCT examinations by examination protocol and patient age. Higher doses were associated with younger age (p=0.0185) and higher kVp (p=0.0399). Comparison of the difference between examinations of each foot independently vs. simultaneous examination of both feet demonstrated a reduction in total dose when both feet are examined together (p=0.0124). Table 5 provides effective doses for medium field of view CBCT examinations of a single foot. As with the largest field of view, higher doses were associated with increasing mAs, higher kVp, and younger age. A small reduction in dose is seen when examining the anterior aspect of the foot (toe at edge of field) as opposed to the posterior aspect of the foot (heal at edge of field). Table 6 provides effective doses for small field of view CBCT examinations. Again, higher dose is associated with younger age and scanning of the posterior aspect of the foot. Table 7 provides effective doses for combined Anterio-Posterior, Lateral, and oblique conventional 2D projections. 
Results

Discussion
Although historical concern with the risk of radiographic imaging of the foot dates back to the use of fluoroscopy to fit shoes, little dose and risk information about currently used imaging modalities is available [18] .
Doses for children in this study were estimated based on reported differences in marrow percentage and proportion of lower leg exposed during imaging. Because an adult phantom foot was used in this study, actual pediatric doses are likely to be marginally lower due to reduced scattering absorption within a smaller volume of tissue. Automatic exposure control might be expected to further reduce MDCT doses for a smaller foot size. Effective doses for a five-year old patient represent a high dose limit for PedCAT® examinations; however, many five year olds would not meet the height requirement for use of the PedCAT® for foot examination. Means from height and age tables suggest that patients would not routinely meet the PedCAT® height restrictions until the age of eight. The majority of podiatric and foot orthopedic patients will be adults. Therefore, the adult range of effective dose for the PedCAT® examination options will be typical. This ranges from less than a microsievert for a small field examination of the anterior foot, to a high of a little more that 10 µSv for a two-foot, grid-enhanced examination. By comparison, the standard protocol MDCT scan produced a dose of 25 µSv while the 3-projection conventional 2D series provided less than 1 µSv of dose. To place these doses in perspective, a standard MDCT scan produced an effective dose comparable to 4 days of per capita background exposure for the average US resident (8 µSv/day) [19] . The highest dose, large FOV PedCAT® examination, is just a little more than a single day of background radiation.
Conclusion
The effective dose for small FOV CBCT examinations is comparable to 1-3 hours of per-capita background dose. Such doses are negligible; therefore, the dose of radiation should not be a concern when considering the use of PedCAT® CBCT imaging for foot/ankle examination.
